DOC vs NBIX · P/E 62, rev $2.70B vs P/E 45, rev $2.36B
Healthpeak Properties Inc (DOC) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Healthpeak Properties Inc (DOC) is a reit - healthcare facilities company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DOC revenue for 2024-12-31 was $2.70B. Net income was $267.3M. Revenue was up 23.8% from 2023-12-31 to 2024-12-31. DOC currently screens at market cap $13.64B and trailing P/E 61.8.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
DOC currently screens at market cap $13.64B and trailing P/E 61.8. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the DOC and NBIX stock pages for the full models.
Not investment advice.